CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.2200
-0.0050 (-2.22%)
At close: Oct 30, 2026
CytoDyn Employees
CytoDyn had 14 employees as of May 31, 2026. The number of employees increased by 1 or 7.69% compared to the previous year. That makes CytoDyn the 39,458th largest employer in the world and 5,796th in the United States.
Employees
14
Change (1Y)
1
Growth (1Y)
7.69%
Revenue / Employee
n/a
Profits / Employee
-$4,184,071
Market Cap
323.29M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| May 31, 2026 | 14 | 1 | 7.69% |
| May 31, 2025 | 13 | 4 | 44.44% |
| May 31, 2024 | 9 | -3 | -25.00% |
| May 31, 2023 | 12 | -11 | -47.83% |
| May 31, 2022 | 23 | -1 | -4.17% |
| May 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sangamo Therapeutics | 142 |
| Northwest Biotherapeutics | 105 |
| Silence Therapeutics | 88 |
| Vaxart | 65 |
| Nuo Therapeutics | 10 |
| Cell Source | 1 |
CytoDyn News
- 4 days ago - CytoDyn Presents Updated Leronlimab Data in Metastatic Colorectal Cancer at ESMO Congress 2026 - GlobeNewsWire
- 11 days ago - CytoDyn Appoints Robert E. Hoffman as Chief Executive Officer - GlobeNewsWire
- 11 days ago - CytoDyn Transcript: Investor update - Transcripts
- 11 days ago - CytoDyn Proxy statement: Proxy filing - Filings
- 15 days ago - CytoDyn to Host Investor Webcast - GlobeNewsWire
- 16 days ago - CytoDyn Quarterly report: Q1 2027 - Filings
- 22 days ago - CytoDyn to Present Updated Data from Phase 2 CLOVER Clinical Study at ESMO Congress 2026 - GlobeNewsWire
- 4 weeks ago - CytoDyn Proxy statement: Proxy filing - Filings